scispace - formally typeset
B

Bianka Leitner

Researcher at Ludwig Maximilian University of Munich

Publications -  10
Citations -  448

Bianka Leitner is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Quality of life & Tourette syndrome. The author has an hindex of 6, co-authored 10 publications receiving 350 citations.

Papers
More filters
Journal ArticleDOI

The role of inflammation in schizophrenia

TL;DR: Anti-inflammatory effects of antipsychotics, therapeutic effects of anti-inflammtory compounds, genetic, biochemical, and immunological findings point to a major role of inflammation in schizophrenia.
Journal ArticleDOI

Functional outcome and quality of life in Tourette's syndrome after deep brain stimulation of the posteroventrolateral globus pallidus internus: long-term follow-up

TL;DR: Although improvement of tics seems to be positively correlated with improved functional outcome, symptomatic improvement may lead to unexpected major psychosocial changes – which both the patient and the clinicians in charge – should be prepared for.
Journal ArticleDOI

Prefrontal tDCS and sertraline in obsessive compulsive disorder: a case report and review of the literature.

TL;DR: The first report on a patient with treatment-refractory OC disorder treated with sertraline and an enhanced prefrontal tDCS protocol with a classic left-anodal/right cathodal montage experiencing a 22% reduction of OC symptoms as well as reduction in depression and anxiety symptoms is provided.
Journal ArticleDOI

Cathodal tDCS Over Motor Cortex Does Not Improve Tourette Syndrome: Lessons Learned From a Case Series.

TL;DR: The results do not support earlier findings of extensive therapeutic effects of cathodal transcranial direct current stimulation on tics in patients with GTS and show that prediction of stimulation effects on a targeted brain area remains inaccurate.
Journal ArticleDOI

Safety of Repeated Twice-daily 30 Minutes of 2 mA tDCS in Depressed Patients

TL;DR: Transcranial direct stimulation is gaining growing importance as a therapeutic tool in neuropsychiatric disorders and seems to be safe even when applied extensively and preliminary data suggest safety and tolerability of twice-daily 30 min tDCS even in a prolonged protocol.